miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling: miR-1205/DNAJB1 reverses docetaxel chemoresistance in TNBC

Chemoresistance is the major cause of therapeutic failure in human triple negative breast carcinoma (TNBC). Docetaxel (DOC), a first-line therapeutic drug in TNBC treatment, is limited for long-term use due to the development of chemoresistance. Thus, overcoming chemoresistance of DOC remains an imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yongxiang, Zhang, Jinqiu, Ma, Tao, Chen, Daozhen, Lu, Daru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909320/
https://www.ncbi.nlm.nih.gov/pubmed/35130632
http://dx.doi.org/10.3724/abbs.2021006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909320/
https://www.ncbi.nlm.nih.gov/pubmed/35130632
http://dx.doi.org/10.3724/abbs.2021006

Ejemplares similares